Insider Trading activities of Savient Pharmaceuticals Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Savient Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Savient Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Savient Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is SVNT. The reporting company's CIK number is 722104.
The total value of stock buying since 2005 is $678,839.
The total value of stock sales since 2005 is $11,758,651.
The total value of stock option exercises since 2005 is $1,571,446.


Go to page:  1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Savient Pharmaceuticals Inc insiders (SVNT) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-01-07 Yachmetz Philip K (EVP, Chief Business Officer) Sale 5,000 23.02 115,105
2008-01-07 Yachmetz Philip K (EVP, Chief Business Officer) Option Ex 5,000 2.60 13,000
2008-01-07 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 5,000 23.00 115,025
2008-01-07 Horowitz Zebulun D (SVP, Chief Medical Officer) Option Ex 5,000 2.52 12,600
2008-01-07 Clement Christopher G (President & CEO) Sale 5,000 23.00 115,000
2008-01-04 Yachmetz Philip K (EVP, Chief Business Officer) Sale 5,000 23.27 116,329
2008-01-04 Yachmetz Philip K (EVP, Chief Business Officer) Option Ex 5,000 2.78 13,899
2008-01-04 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 5,000 23.26 116,320
2008-01-04 Horowitz Zebulun D (SVP, Chief Medical Officer) Option Ex 5,000 2.52 12,600
2008-01-03 Hayden Brian J (SVP, Chief Financial Officer) Sale 5,000 24.26 121,285
2008-01-03 Yachmetz Philip K (EVP, Chief Business Officer) Sale 5,000 24.26 121,285
2008-01-03 Yachmetz Philip K (EVP, Chief Business Officer) Option Ex 5,000 2.60 13,000
2008-01-03 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 5,000 24.24 121,225
2008-01-03 Horowitz Zebulun D (SVP, Chief Medical Officer) Option Ex 5,000 2.52 12,600
2008-01-03 Conrad Herbert J (Director) Sale 5,000 24.24 121,199
2008-01-03 Conrad Herbert J (Director) Option Ex 5,000 3.20 16,005
2008-01-03 Clement Christopher G (President & CEO) Sale 5,000 24.23 121,160
2008-01-02 Hamelin Paul (SVP, Commercial Operations) Sale 2,375 23.60 56,050
2008-01-02 Hamelin Paul (SVP, Commercial Operations) Option Ex 2,375 12.11 28,761
2008-01-02 Hayden Brian J (SVP, Chief Financial Officer) Sale 5,000 23.47 117,360
2008-01-02 Hayden Brian J (SVP, Chief Financial Officer) Option Ex 5,000 5.33 26,650
2008-01-02 Yachmetz Philip K (EVP, Chief Business Officer) Sale 5,000 23.47 117,330
2008-01-02 Yachmetz Philip K (EVP, Chief Business Officer) Option Ex 5,000 2.42 12,100
2008-01-02 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 5,000 23.47 117,340
2008-01-02 Horowitz Zebulun D (SVP, Chief Medical Officer) Option Ex 5,000 2.52 12,600
2008-01-02 Conrad Herbert J (Director) Sale 5,000 23.60 118,000
2008-01-02 Conrad Herbert J (Director) Option Ex 5,000 2.96 14,800
2008-01-02 Clement Christopher G (President & CEO) Sale 5,000 23.95 119,760
2007-12-19 Lamm Robert (SVP, Quality & Reg Affairs) Sale 5,000 20.75 103,745
2007-12-19 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 5,000 3.82 19,100
2007-12-18 Lamm Robert (SVP, Quality & Reg Affairs) Sale 5,000 20.10 100,515
2007-12-18 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 5,000 4.67 23,350
2007-12-18 Hayden Brian J (SVP, Chief Financial Officer) Sale 5,000 20.09 100,440
2007-12-18 Hayden Brian J (SVP, Chief Financial Officer) Option Ex 5,000 5.33 26,650
2007-12-17 Hayden Brian J (SVP, Chief Financial Officer) Sale 5,000 19.91 99,535
2007-12-17 Hayden Brian J (SVP, Chief Financial Officer) Option Ex 5,000 5.33 26,650
2007-12-14 Hamelin Paul (SVP, Commercial Operations) Sale 3,333 17.12 57,057
2007-12-14 Hamelin Paul (SVP, Commercial Operations) Option Ex 3,333 5.11 17,031
2007-12-14 Lamm Robert (SVP, Quality & Reg Affairs) Sale 5,000 18.48 92,425
2007-12-14 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 5,000 4.67 23,350
2007-12-14 Hayden Brian J (SVP, Chief Financial Officer) Sale 5,000 17.12 85,595
2007-12-14 Hayden Brian J (SVP, Chief Financial Officer) Option Ex 5,000 5.33 26,650
2007-12-13 Hamelin Paul (SVP, Commercial Operations) Sale 5,000 17.74 88,720
2007-12-13 Hamelin Paul (SVP, Commercial Operations) Option Ex 5,000 5.11 25,550
2007-12-13 Lamm Robert (SVP, Quality & Reg Affairs) Sale 5,000 17.84 89,200
2007-12-13 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 5,000 4.67 23,350
2007-12-13 Hayden Brian J (SVP, Chief Financial Officer) Sale 5,000 17.18 85,890
2007-12-13 Hayden Brian J (SVP, Chief Financial Officer) Option Ex 5,000 5.33 26,650
2007-12-10 Hamelin Paul (SVP, Commercial Operations) Sale 2,353 15.22 35,819
2007-12-10 Lamm Robert (SVP, Quality & Reg Affairs) Sale 2,368 15.32 36,287
2007-12-10 Yachmetz Philip K (EVP, Chief Business Officer) Sale 7,774 15.22 118,343
2007-12-10 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 6,046 15.31 92,588
2007-12-10 Clement Christopher G (President & CEO) Sale 11,229 15.26 171,354
2007-11-30 Conrad Herbert J (Director) Sale 5,000 14.03 70,130
2007-11-30 Conrad Herbert J (Director) Option Ex 5,000 12.74 63,700
2007-11-29 Conrad Herbert J (Director) Sale 2,500 14.74 36,850
2007-11-29 Conrad Herbert J (Director) Option Ex 2,500 12.74 31,850
2007-11-28 Conrad Herbert J (Director) Sale 2,500 13.75 34,375
2007-11-28 Conrad Herbert J (Director) Option Ex 2,500 11.81 29,532
2007-10-16 Lamm Robert (SVP, Quality & Reg Affairs) Sale 2,600 15.52 40,352
2007-10-16 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 2,600 4.67 12,142
2007-10-15 Hamelin Paul (SVP, Commercial Operations) Sale 1,667 15.52 25,871
2007-10-15 Hamelin Paul (SVP, Commercial Operations) Option Ex 1,667 5.11 8,518
2007-10-15 Lamm Robert (SVP, Quality & Reg Affairs) Sale 5,000 15.52 77,600
2007-10-15 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 5,000 4.67 23,350
2007-10-10 Conrad Herbert J (Director) Sale 5,000 15.11 75,550
2007-10-10 Conrad Herbert J (Director) Option Ex 5,000 11.81 59,065
2007-10-09 Conrad Herbert J (Director) Sale 5,000 15.12 75,585
2007-10-09 Conrad Herbert J (Director) Option Ex 5,000 7.41 37,030
2007-10-08 Lamm Robert (SVP, Quality & Reg Affairs) Sale 5,000 15.52 77,600
2007-10-08 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 5,000 4.67 23,350
2007-10-08 Conrad Herbert J (Director) Sale 4,629 15.52 71,842
2007-10-08 Conrad Herbert J (Director) Option Ex 4,629 7.64 35,365
2007-10-05 Hamelin Paul (SVP, Commercial Operations) Sale 2,500 15.52 38,800
2007-10-05 Hamelin Paul (SVP, Commercial Operations) Option Ex 2,500 5.11 12,775
2007-10-05 Lamm Robert (SVP, Quality & Reg Affairs) Sale 1,588 15.52 24,645
2007-10-05 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 1,588 4.67 7,415
2007-10-05 Conrad Herbert J (Director) Sale 2,871 15.52 44,557
2007-10-05 Conrad Herbert J (Director) Option Ex 2,871 7.88 22,609
2007-10-03 Hamelin Paul (SVP, Commercial Operations) Sale 2,500 15.52 38,800
2007-10-03 Hamelin Paul (SVP, Commercial Operations) Option Ex 2,500 5.11 12,775
2007-10-03 Lamm Robert (SVP, Quality & Reg Affairs) Sale 5,000 15.52 77,600
2007-10-03 Lamm Robert (SVP, Quality & Reg Affairs) Option Ex 5,000 4.67 23,350
2007-10-03 Conrad Herbert J (Director) Sale 2,500 15.52 38,800
2007-10-03 Conrad Herbert J (Director) Option Ex 2,500 7.88 19,687
2007-05-23 Hamelin Paul (SVP, Commercial Operations) Sale 1,220 14.35 17,504
2007-04-12 Yachmetz Philip K (EVP, Chief Business Officer) Sale 3,805 12.06 45,903
2007-04-12 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 3,805 12.01 45,705
2007-04-12 Clement Christopher G (President & CEO) Sale 7,608 12.00 91,296
2007-03-05 Hayden Brian J (SVP, Chief Financial Officer) Sale 4,450 12.52 55,714
2007-03-05 Yachmetz Philip K (EVP, Chief Business Officer) Sale 20,881 12.53 261,638
2007-03-05 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 18,942 12.50 236,775
2007-03-05 Clement Christopher G (President & CEO) Sale 34,231 12.59 430,968
2007-02-15 Yachmetz Philip K (EVP, Chief Business Officer) Sale 3,051 14.44 44,044
2007-02-15 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 2,517 14.47 36,410
2007-02-15 Clement Christopher G (President & CEO) Sale 7,624 14.49 110,441
2007-01-22 Lamm Robert (SVP, Quality & Reg Affairs) Sale 2,096 14.98 31,389
2006-12-04 Tendler David (Director) Sale 900 11.68 10,512
2006-09-15 Klein Joseph Iii (Director) Buy 3,000 6.30 18,900
2006-09-01 Klein Joseph Iii (Director) Buy 3,000 6.50 19,494
2006-08-15 Klein Joseph Iii (Director) Buy 3,000 5.79 17,370
2006-08-01 Klein Joseph Iii (Director) Buy 3,000 5.88 17,640
2006-07-18 Klein Joseph Iii (Director) Buy 3,000 5.19 15,570
2006-07-03 Klein Joseph Iii (Director) Buy 3,000 5.34 16,020
2006-06-01 Klein Joseph Iii (Director) Buy 3,000 5.83 17,502
2006-05-25 Heller Alan L (Director) Buy 10,000 5.49 54,910
2006-04-12 Yachmetz Philip K (SVP, General Counsel) Sale 4,992 5.87 29,293
2006-04-12 Horowitz Zebulun D (SVP, Chief Medical Officer) Sale 6,159 5.87 36,153
2006-04-12 Clement Christopher G (President & CEO) Sale 10,313 5.87 60,537
2005-06-13 Weissbach Herbert (Director) Buy 4,300 3.47 14,921
2005-06-07 Hayward Surry Jeremy (Director) Buy 7,500 3.26 24,450
2005-05-18 Yachmetz Philip K (SVP, General Counsel) Buy 10,000 3.18 31,780
2005-05-18 Clement Christopher G (CEO) Buy 15,000 3.09 46,350
2005-05-17 Fink David L (SVP, Commercial Oper) Buy 20,000 3.06 61,200
2005-05-17 Gyenes Lawrence A (SVP, Chief Financial) Buy 15,000 3.08 46,125
Go to page:  1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of SVNT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Savient Pharmaceuticals Inc (symbol SVNT, CIK number 722104) see the Securities and Exchange Commission (SEC) website.